BTIG Maintains Their Hold Rating on Intuitive Surgical (ISRG)

In a report released today, Ryan Zimmerman from BTIG maintained a Hold rating on Intuitive Surgical (ISRGResearch Report). The company’s shares closed last Wednesday at $808.37, close to its 52-week high of $826.81.

According to, Zimmerman is a 5-star analyst with an average return of 22.5% and a 63.7% success rate. Zimmerman covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Staar Surgical Company, and Zimmer Biomet Holdings.

Currently, the analyst consensus on Intuitive Surgical is a Moderate Buy with an average price target of $696.25.

See today’s analyst top recommended stocks >>

Intuitive Surgical’s market cap is currently $92.68B and has a P/E ratio of 92.80. The company has a Price to Book ratio of 10.83.

Based on the recent corporate insider activity of 55 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of ISRG in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.